TIL Therapy: A New Melanoma Treatment 30 Years in the Making
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
Category: Research
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
A plenary session at the AACR Annual Meeting 2024 explored how metastases adapt to—and help shape—their new environments.
At the AACR Annual Meeting 2024, researchers discussed innovative approaches to decipher the complexities of tumor ecosystems.
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
Researchers are exploring new options for kidney cancer treatments.
Researchers are examining the gut microbiome to find better ways to diagnose and manage colorectal cancer.
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
Researchers are finding early clinical success in developing more targeted treatments for bile duct cancer, also called cholangiocarcinoma.
In part 4 of our 2024 Experts Forecast, Paul Workman, PhD, shares thoughts on cutting-edge advances in oncology drug...
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...